Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Guidelines. a) Use of echocardiography. p 228-236. b) Cardiac radionuclide imaging. p 322-323. c) Management of heart failure. p 652-658. d) Ambulatory monitoring and electrophysiological testing. p 767-774. e) Use of cardiac pacemakers and antiarrhythmia devices. p 810-814. f) Diagnosis and management of acute myocardial infarction. p 1219-1231. g) Management of unstable angina/non-ST segment elevation myocardial infarction. p 1264-1272. h) Management of chronic ischemic heart disease. p 1353-1363. i) Prevention, evaluation, and management of infective endocarditis. p 1748-1750. j) Summary of guidelines for reducing cardiac risk with noncardiac surgery. p 2096-2097.

Guidelines. a) Use of echocardiography. p 228-236. b) Cardiac radionuclide imaging. p 322-323. c) Management of heart failure. p 652-658. d) Ambulatory monitoring and electrophysiological testing. p 767-774. e) Use of cardiac pacemakers and antiarrhythmia devices. p 810-814. f) Diagnosis and management of acute myocardial infarction. p 1219-1231. g) Management of unstable angina/non-ST segment elevation myocardial infarction. p 1264-1272. h) Management of chronic ischemic heart disease. p 1353-1363. i) Prevention, evaluation, and management of infective endocarditis. p 1748-1750. j) Summary of guidelines for reducing cardiac risk with noncardiac surgery. p 2096-2097. . In: Braunwald E, Zipes DP, Libby. Heart Disease. 6th ed. Philadelphia: W.B. Saunders, Co. 2001.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.